HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Davidson Selected Research

J Davidson Research Topics

Disease

8Neoplasms (Cancer)
11/2016 - 10/2000
5Infections
09/2018 - 10/2009
3Type 2 Diabetes Mellitus (MODY)
12/2013 - 09/2004
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2000 - 04/2000
2Pain (Aches)
01/2019 - 04/2014
2Fever (Fevers)
09/2018 - 07/2001
2Diabetes Mellitus
10/2015 - 07/2013
2Heart Failure
10/2015 - 01/2000
1Leukopenia
04/2020
1Thrombocytopenia (Thrombopenia)
04/2020
1Intestinal Failure
01/2020
1Fistula
01/2020
1Lupus Nephritis
04/2019
1Rare Diseases (Rare Disease)
01/2019
1Chronic recurrent multifocal osteomyelitis
01/2019
1Congenital Diaphragmatic Hernias
01/2019
1Multiple Myeloma
09/2018
1Bacterial Infections (Bacterial Infection)
09/2018
1Autoimmune Diseases (Autoimmune Disease)
09/2015
1Postoperative Pain
04/2014
1Body Weight (Weight, Body)
12/2013
1Anaphylaxis (Anaphylactic Shock)
10/2013
1Insulin Resistance
07/2013
1Diabetic Retinopathy (Retinopathy, Diabetic)
07/2013
1Cardiovascular Diseases (Cardiovascular Disease)
07/2013
1Inflammation (Inflammations)
07/2013
1Albuminuria
07/2013
1Sepsis (Septicemia)
05/2010
1Myositis (Idiopathic Inflammatory Myopathies)
10/2008
1Shock
06/2005
1Breast Neoplasms (Breast Cancer)
06/2005
1Hypercholesterolemia
09/2004
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
12/2001
1Syndrome (Syndromes)
12/2001
1Carotid Stenosis (Carotid Artery Stenosis)
12/2001
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
11/2001
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
07/2001

Drug/Important Bio-Agent (IBA)

2saxagliptinFDA Link
10/2015 - 07/2013
2Insulin (Novolin)FDA Link
07/2013 - 09/2004
2Sertraline (Zoloft)FDA LinkGeneric
12/2001 - 11/2001
1Complement System Proteins (Complement)IBA
04/2020
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
04/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2019
1Adalimumab (Humira)FDA Link
01/2019
1Pamidronate (Aredia)FDA LinkGeneric
01/2019
1Levofloxacin (Levaquin)FDA Link
09/2018
1Doxycycline (Periostat)FDA LinkGeneric
09/2018
1Ciprofloxacin (Cipro)FDA LinkGeneric
09/2018
1FluoroquinolonesIBA
09/2018
1ChlorineIBA
05/2017
1MucinsIBA
11/2016
1tetrachloroisophthalonitrile (Bravo)IBA
05/2016
1Biological ProductsIBA
09/2015
1Investigational DrugsIBA
09/2015
1Remifentanil (Ultiva)FDA Link
04/2014
1Metformin (Glucophage)FDA LinkGeneric
12/2013
1Glucose (Dextrose)FDA LinkGeneric
12/2013
1CanagliflozinIBA
12/2013
1Sitagliptin Phosphate (Januvia)FDA Link
12/2013
1OvalbuminIBA
10/2013
1Dipeptidyl-Peptidase IV InhibitorsIBA
07/2013
1Biomarkers (Surrogate Marker)IBA
07/2013
1EnzymesIBA
10/2009
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2009
1Indicators and Reagents (Reagents)IBA
10/2009
1Protein Tyrosine PhosphatasesIBA
10/2008
1AutoantibodiesIBA
10/2008
1Adenosine Triphosphate (ATP)IBA
06/2005
1Purinergic AgonistsIBA
06/2005
1BoronIBA
11/2004
1tetraphenylporphyrinIBA
11/2004
1copper tetracarboranyltetraphenylporphyrinIBA
11/2004
1CholesterolIBA
09/2004
1Hypoglycemic Agents (Hypoglycemics)IBA
09/2004
1Atorvastatin (Lipitor)FDA Link
09/2004
1factor V LeidenIBA
12/2001
1HomocysteineIBA
12/2001
1Platelet Membrane GlycoproteinsIBA
12/2001
1Prothrombin (Factor II)IBA
12/2001
1Human Platelet AntigensIBA
12/2001
1Antiphospholipid AntibodiesIBA
12/2001
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
12/2001
1Ketoprofen (Orudis)FDA LinkGeneric
07/2001
1Poly I-CIBA
07/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2001
1ProstaglandinsIBA
07/2001
1Dinoprostone (PGE2)FDA Link
07/2001
1LipopolysaccharidesIBA
07/2001
1Interleukin-1 (Interleukin 1)IBA
07/2001

Therapy/Procedure

4Radiotherapy
01/2003 - 04/2000
3Therapeutics
09/2015 - 05/2010
2Stem Cell Transplantation
02/2001 - 10/2000
1Length of Stay
01/2020
1Parenteral Nutrition
01/2020
1Enterostomy
01/2020
1Investigational Therapies (Experimental Therapy)
01/2019
1Catheters
08/2016
1Analgesia
04/2014
1Surgical Amputation (Amputations)
07/2013
1Activities of Daily Living (ADL)
07/2001